STATE-OF-THE-ART REVIEW

Department of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano; Department of Cardiology, National Heart Foundation Hospital and

Despite notable advancements in the management of coronary artery disease and myocardial infarction, these conditions remain the leading cause of mortality worldwide. The review discusses the pathophysiological mechanisms of MI, the importance of timely revascularization, and the ongoing challenges in improving patient outcomes. It emphasizes the need for adjunctive pharmacological agents and optimized secondary prevention strategies to mitigate post-MI complications and reduce the risk of recurrent events.